glucocorticoid
gc
usag
common
nontraumat
caus
osteonecrosi
femor
head
despit
strong
associ
gc
underli
mechan
unclear
investig
propos
direct
indirect
effect
gc
cell
indirect
direct
mechan
remain
intim
relat
often
result
posit
feedback
loop
potenti
diseas
process
howev
direct
effect
particular
apoptosi
recent
shown
increasingli
import
suppress
osteoblast
osteoclast
precursor
product
increas
apoptosi
osteoblast
osteocyt
prolong
lifespan
osteoclast
apoptosi
endotheli
cell
ec
direct
effect
gc
usag
elev
blood
pressur
sever
pathway
may
rais
risk
clot
format
highdos
gc
also
decreas
tissu
plasminogen
activ
activ
tpa
increas
plasma
plasminogen
activ
antigen
level
increas
procoagul
potenti
gc
inhibit
angiogenesi
alter
bone
repair
nitric
oxid
metabol
also
result
also
gc
treatment
modul
vasoact
mediat
noradrenalin
bradykinin
thu
gc
act
regul
local
blood
flow
modul
vascular
respons
vasoact
substanc
vasoconstrict
induc
intraoss
femor
head
arteri
caus
femor
head
ischemia
gc
also
caus
ischemia
increas
intraoss
pressur
subsequ
decreas
blood
flow
femor
head
apoptosi
ec
well
elev
level
adipogenesi
fat
hypertrophi
bone
marrow
difficult
predict
patient
receiv
specif
dose
gc
develop
indic
individu
differ
steroid
sensit
potenti
addit
mechan
textbook
model
multipl
hit
theori
greater
number
risk
factor
risk
increas
effort
need
better
comprehend
role
gc
newer
data
gc
action
upon
endotheli
cell
region
endotheli
bed
dysfunct
theori
shed
new
light
particular
gc
mechan
better
understand
gc
pathomechan
lead
better
treatment
option
harvey
cush
recogn
advers
effect
hypercortisol
bone
earli
current
million
american
requir
glucocorticoid
gc
drug
part
treatment
regim
depend
durat
therapi
dose
steroid
user
develop
bone
loss
lead
fractur
steroid
user
develop
degre
debilit
skelet
disord
gc
known
common
nontraumat
caus
felson
anderson
perform
metaanalysi
demonstr
mean
daili
gc
dose
strongli
correl
diseas
review
increas
rate
postul
everi
mgday
increas
mean
daili
oral
dose
prednison
first
month
therapi
seri
report
agre
sustain
larg
dose
gc
requir
sustain
symptomat
rare
report
low
dose
gc
exposur
probabl
relat
underli
medic
condit
coagulopath
dyscrasia
genet
suscept
unfortun
patient
symptomat
femor
head
eventu
need
surgeri
usual
total
hip
arthroplasti
tha
within
year
onset
averag
age
present
year
age
patient
often
requir
multipl
increasingli
difficult
surgeri
cours
lifetim
complet
understand
gc
use
associ
would
help
new
research
reveal
may
diseas
process
effect
bone
cell
alon
endotheli
cell
suscept
may
actual
import
pertin
evolut
pathophysiolog
femor
head
sever
mechan
postul
role
gcinduc
fig
investig
assum
direct
effect
drug
bone
cell
older
theori
consid
indirect
effect
gc
via
influenc
gonad
parathyroid
gland
recent
shown
secondari
hyperparathyroid
hypogonad
appear
major
role
pathogenesi
gcinduc
result
fractur
unlik
earlier
think
thu
direct
effect
gc
bone
cell
respons
undoubtedli
import
indirect
effect
action
gc
believ
mediat
glucocorticoid
receptor
gr
vitro
studi
shown
presenc
gr
human
murin
osteoblast
osteocyt
osteoclast
first
time
silvestrini
et
al
show
gr
present
cartilag
prolif
hypertroph
zone
osteoblast
ostocyt
osteoclast
femur
young
adult
rat
natur
synthet
gc
bind
gr
produc
major
conform
chang
result
nuclear
transloc
transrepress
transcript
factor
includ
nuclear
factor
b
caus
modif
pivot
mediat
innat
adapt
immun
due
abil
gc
modul
immun
respons
extens
use
antiinflammatori
agent
immun
respons
act
commonli
fa
pathway
one
bestcharacter
apoptot
pathway
bind
fasl
fasr
caus
receptor
oligomer
recruit
adapt
protein
fadd
interact
initi
caspas
cascad
lead
apoptosi
immunogen
cell
dexamethason
dexa
gc
could
also
interact
protooncogen
cjun
cfo
gr
interact
describ
gc
respons
element
gre
two
transcript
factor
locat
close
togeth
rel
rapid
induct
apoptosi
vitro
dexamethasonetr
tlymphocyt
occur
within
hour
exposur
despit
apoptosi
effect
gc
tlymphocyt
dexa
promot
prolifer
protect
cell
apoptosi
andor
necrosi
particular
condit
effect
seen
corneal
epitheli
cell
keratocyt
epitheli
cell
mammari
gland
hepatocyt
thymocyt
gr
gene
respons
may
posit
neg
regul
paradox
biphas
effect
differ
respons
differ
type
cell
differ
dosag
instanc
dexa
would
increas
cell
prolifer
low
concentr
brain
tumor
cell
induc
cellular
apoptosi
andor
necrosi
high
concentr
brain
tumor
cell
corneal
endotheli
cell
although
clearli
defin
dual
effect
gc
may
also
result
crosstalk
nuclear
comodul
interact
transcript
factor
osteoblast
osteocyt
femor
cortex
mostli
undergo
apoptosi
lengthi
period
gc
medic
vivo
clinic
studi
abund
apoptot
osteocyt
cell
line
cancel
bone
found
juxtapos
subtot
fractur
crescent
femur
patient
gc
excess
similar
studi
calder
colleagu
shown
widespread
apoptosi
osteoblast
osteocyt
steroidand
alcoholinduc
osteonecrosi
patient
obrien
colleagu
shown
mice
harbour
dehydrogenas
type
transgen
protect
gcinduc
apoptosi
osteocyt
osteoblast
highaffin
naddepend
enzym
convert
biolog
activ
gc
inact
metabolit
subsequ
inactiv
gc
would
fail
activ
gr
despit
prevent
gcinduc
decreas
bone
format
transgen
mice
prevent
earli
rapid
bone
loss
osteoclast
protect
gc
studi
shown
earli
loss
bone
gc
excess
caus
direct
effect
gc
osteoclast
extend
life
span
osteoclast
surviv
differenti
regul
factor
produc
stromal
osteoblast
cell
critic
factor
receptor
activ
nfb
rank
ligand
member
tumor
necrosi
factor
tnf
ligand
famili
rank
ligand
macrophagecolonystimul
factor
crucial
suffici
osteoclast
differenti
absenc
marrow
stromal
cell
rank
ligand
also
prolong
surviv
differenti
osteoclast
quantiti
rank
ligand
osteoprotegerin
rais
gctreat
osteoblast
consequ
differenti
osteoclast
block
therefor
complet
clear
process
apoptosi
bone
cell
alon
would
result
apart
direct
effect
gc
shown
gc
excess
could
affect
birth
rate
bone
cell
weinstein
et
al
administ
prednisolon
mice
day
found
decreas
bone
densiti
serum
osteocalcin
cancel
bone
area
along
trabecular
narrow
chang
accompani
diminish
bone
format
turnov
impair
osteoblastogenesi
osteoclastogenesi
therefor
assum
pathogenesi
gcinduc
bone
diseas
may
least
partial
caus
suppress
osteoblast
osteoclast
precursor
product
bone
marrow
increas
apoptosi
osteoblast
osteocyt
prolong
lifespan
osteoclast
also
postul
gcinduc
osteocyt
apoptosi
disrupt
mechanosensori
function
osteocyt
network
believ
constitut
mechanosensor
apparatu
control
repair
process
bone
may
start
inexor
sequenc
event
lead
femor
head
collaps
addit
end
result
fractur
collaps
may
facilit
coexist
osteoporosi
mediat
gcinduc
osteoblast
apoptosi
bone
morphogen
gene
express
also
decreas
gc
treatment
individu
suscept
gcinduc
decreas
osteocalcin
gene
express
like
gc
abund
effect
endotheli
cell
line
sinusoid
inner
layer
blood
vessel
femor
head
experiment
evid
gcinduc
hypertens
indic
rais
arteri
blood
pressur
relat
elev
peripher
resist
gc
action
result
vasoact
mediat
discuss
anoth
hypothesi
advanc
mechan
enhanc
peripher
resist
decreas
number
function
microvessel
capillari
rarefact
gc
directli
injur
endotheli
cell
enhanc
hypercoagul
studi
jacob
et
al
damag
abnorm
reticular
vessel
suggest
underli
mechan
damag
endotheli
cell
may
result
abnorm
blood
coagul
thrombi
format
occur
distal
site
arteri
occlus
prostaglandin
f
metabolit
prostaglandin
pgi
consid
marker
endotheli
cell
injuri
pgi
mainli
produc
vascular
endotheli
cell
strongli
dilat
blood
vessel
inhibit
platelet
aggreg
studi
et
al
level
decreas
significantli
compar
control
rabbit
model
induc
endotoxin
gc
suggest
anoth
endotheli
cell
impair
may
gcmediat
postul
apoptot
endotheli
cell
death
serv
mechan
capillari
rarefact
glucocorticoidmedi
hypertens
therefor
plausibl
gcinduc
hypertens
femor
head
disturb
blood
flow
femor
head
vessel
abort
repair
process
furthermor
enhanc
blood
pressur
blood
vessel
femor
head
could
increas
thrombin
convert
fibrinogen
fibrin
form
fibrin
clot
studi
enzym
involv
coagul
cascad
shown
thrombin
elev
establish
phase
hypertens
consequ
rais
blood
pressur
shown
vivo
ex
vivo
studi
lower
dose
sever
type
gc
initi
inhibit
arteri
thrombosi
inhibit
platelet
aggreg
higher
dose
effect
counteract
signific
inhibit
fibrinolyt
activ
latter
shown
occur
result
decreas
tissu
plasminogen
activ
activ
tpa
increas
plasma
plasminogen
activ
antigen
level
decreas
fibrinolyt
activ
may
consequ
increas
describ
patient
studi
perform
yamamoto
et
al
dexa
upregul
gene
express
human
umbil
vein
endotheli
cell
huvec
stimul
condit
postul
inflammatori
condit
dexa
exposur
condit
could
promot
blood
procoagul
effect
act
vascular
endotheli
cell
furthermor
drescher
et
al
show
anim
model
plasma
fibrinogen
significantli
increas
earli
stage
follow
megados
steroid
treatment
suggest
proinflammatori
condit
steroidinduc
one
could
argu
gc
may
potenti
respons
system
respons
result
case
shown
clinic
signific
sever
joint
result
use
high
dose
gc
howev
except
rather
normal
present
recent
literatur
odd
opinion
whether
system
defect
clot
mechan
actual
account
clinic
signific
sever
studi
reveal
preval
thrombophil
hypofibrinolyt
coagul
abnorm
patient
gcinduc
increas
compar
control
studi
report
signific
differ
level
thrombot
fibrinolyt
factor
gener
irreproduc
system
blood
clot
defect
amongst
patient
concern
dozen
differ
blood
thrombophil
factor
probabl
respons
singl
diseas
process
also
still
unexplain
mani
patient
without
known
system
defect
mechan
femor
head
depend
local
dysregul
coagul
level
femor
head
explain
diseas
process
clot
microcircul
level
like
depend
local
balanc
proand
hypocoagul
factor
endotheli
cell
surfac
bone
region
vascular
bed
upon
system
clot
factor
slichter
et
al
show
endotheli
cell
damag
follow
platelet
thrombu
format
secondari
fibrin
deposit
femor
head
dysbar
li
et
al
also
show
endotheli
cell
damag
well
procoagul
low
fibrinolyt
milieu
potenti
patholog
mechan
gcinduc
intravascular
coagul
intermediari
event
hereditari
acquir
risk
factor
two
form
plasminogen
activ
inhibitor
pai
thromboblast
product
serin
proteas
inhibitor
synthes
releas
endotheli
cell
blood
vessel
wall
exert
regulatori
activ
fibrinolysi
form
complex
tissu
plasminogen
activ
tpa
complex
abil
activ
plasminogen
plasmin
increas
activ
suppress
gener
plasmin
result
hypofibrinolysi
rel
hypercoagul
state
clinic
experiment
studi
activ
tpa
decreas
increas
respect
patient
endotheli
injuri
dysfunct
activ
thrombot
cascad
follow
ischemia
infarct
femor
head
thrombu
format
also
stimul
mechan
microparticl
compos
residu
bodi
apoptot
endotheli
cell
directli
induc
endotheli
dysfunct
follow
activ
thrombot
cascad
apoptosi
endotheli
cell
stimul
bind
thrombocyt
endothelium
induc
platelet
activ
thrombu
format
follow
necrosi
femor
head
repair
process
begin
entri
blood
vessel
necrot
region
follow
bone
resorpt
subsequ
bone
format
sever
essenti
factor
vascular
endotheli
growth
factor
vegf
act
directli
endotheli
cell
induc
angiogenesi
dysregul
essenti
factor
effect
angiogenesi
consequ
repair
process
yang
et
al
use
vegf
gene
transfect
enhanc
repair
rabbit
model
shown
dexa
decreas
synthesi
vegf
protein
measur
elisa
multipotenti
cell
line
deriv
bone
marrow
myofibroblast
cell
induc
capillari
format
produc
endotheli
growth
factor
collagen
harada
show
gc
inhibit
capillari
growth
significantli
suppress
collagen
synthesi
myofibroblast
cell
addit
mechan
may
imped
angiogenesi
one
appear
relat
basement
membran
turnov
determin
part
proteolyt
activ
associ
prolifer
vessel
plasminogen
activ
serin
proteas
convert
plasminogen
plasmin
cleav
extracellular
protein
either
directli
indirectli
result
plasmin
product
alter
cellmatrix
interact
liber
mitogen
angiogen
factor
stimul
endotheli
migrat
prolifer
decreas
fibrinolyt
activ
may
consequ
increas
describ
patient
inhibit
proteolyt
step
involv
vessel
growth
may
underli
part
mechan
gc
induc
addit
gc
constitu
cartilag
well
interferon
shown
potenti
inhibitor
angiogenesi
follow
subchondr
fractur
cartilag
compon
directli
expos
ongo
repair
process
fractur
cleft
cartilag
constitu
may
thu
play
role
develop
andor
continu
diseas
process
explain
local
subchondr
bone
tissu
also
report
secondari
interferon
treatment
multipl
sclerosi
crohn
diseas
leukemia
hemangioma
use
alon
associ
gc
vascular
endotheli
cell
regul
vascular
tone
releas
relax
contract
factor
modul
contractil
activ
vascular
smooth
muscl
cell
gc
excess
caus
overproduct
reactiv
oxygen
speci
ro
superoxid
hydrogen
peroxid
hydroxyl
radic
therebi
perturb
nitric
oxid
avail
vascular
endothelium
event
lead
vascular
complic
patient
gc
excess
nitric
oxid
endotheli
cellderiv
relax
factor
import
vasoact
mediat
reaction
endotheliumdepend
vascular
relax
decreas
avail
due
perturb
synthesi
andor
releas
vascular
endotheli
cell
caus
increas
vascular
resist
gc
excess
enhanc
superoxideinduc
inactiv
eno
endotheli
nitric
oxid
suppress
eno
product
decreas
express
endotheli
nitric
oxid
synthas
eno
synthesi
eno
could
influenc
gc
three
potenti
mechan
direct
injuri
effect
gc
endotheli
cell
repress
eno
activ
increas
blood
lipid
level
eno
sever
anticoagul
action
includ
dilat
blood
vessel
prevent
platelet
aggreg
inhibit
monocyt
adher
endothelium
gcinduc
decreas
bioavail
elicit
vascular
endotheli
dysfunct
lead
insuffici
peripher
circul
thu
potenti
mechan
glucocorticoidinduc
respons
isol
intraoss
femor
head
arteri
later
epiphys
arteri
provid
major
blood
suppli
femor
head
enhanc
longterm
corticosteroid
treatment
month
methylprednisolon
immatur
pig
respons
physiolog
vasoact
substanc
noradrenalin
substanc
p
nitric
oxid
bradykinin
unchang
endothelin
potent
vasoconstrictor
synthes
releas
vascular
endotheli
cell
bind
vascular
smooth
muscl
bone
anoth
studi
drescher
et
al
vasoconstrict
noradrenalin
alter
methylprednisolon
howev
bradykinin
elicit
concentrationdepend
vasodilat
lower
gctreat
vessel
nontreat
vessel
contrast
vasoconstrict
stronger
gctreat
vessel
endothelin
caus
vasoconstrict
increas
intracellular
calcium
level
vascular
smooth
muscl
strongest
vasoconstrict
potenti
among
endothelin
henc
methylprednisolon
shown
enhanc
constrict
femor
head
later
epiphys
arteri
decreas
femor
head
blood
flow
prostacyclin
anoth
potent
vasodil
produc
vascular
smooth
muscl
cell
endotheli
cell
product
decreas
gc
treatment
studi
proteas
involv
blood
pressur
homeostasi
dexa
shown
increas
angiotensinconvert
enzym
aminopeptidas
suppress
kallikreinkinin
system
effect
result
enhanc
angiotensin
ii
angiotensin
iii
level
also
contribut
elev
blood
pressur
suppress
kallikreinkinin
system
dexa
elev
angiotensinconvert
enzym
also
addit
effect
inhibit
vasodil
thu
gc
appear
act
regul
local
blood
flow
modul
vascular
respons
vasoact
substanc
phenomenon
potenti
hypertens
induc
endotheli
cell
apoptosi
discuss
gcinduc
vasoconstrict
intraoss
femor
head
arteri
reduc
blood
flow
caus
inadequ
blood
suppli
femor
head
propos
gc
produc
seriou
intramedullari
fatti
infiltr
effect
fatti
tamponad
medullari
caviti
result
lipocyt
surfac
vascular
sinusoid
result
less
effici
function
vascular
sinusoid
diminish
vascular
area
femor
head
diminish
blood
flow
femor
head
level
lead
secondari
necrosi
vitro
studi
li
et
al
dexainduc
adipogenesi
pluripot
marrow
cell
lineag
clone
balbc
mice
accompani
lipid
vesicl
accumul
within
cell
upregul
express
adipogen
gene
ppar
gamma
downregul
osteogen
gene
express
type
collagen
osteocalcin
effect
steroid
adipogenesi
pluripot
cell
clone
mous
bone
marrow
transfect
traceabl
gene
encod
betagalactosidas
neomycin
resist
investig
vitro
ex
vivo
vivo
mice
treatment
cultur
cell
dexa
produc
accumul
lipid
vesicl
stimul
express
fat
cellspecif
mrna
data
mice
vivo
studi
show
adipogenesi
steroid
treatment
transplant
cell
result
indic
steroidinduc
differenti
potenti
osteogen
marrow
cell
adipocyt
may
contribut
develop
shown
number
adipocyt
cultur
increas
longer
marrow
stromal
cell
exposur
dexa
concentr
dexa
data
vivo
studi
demonstr
adipocyt
bone
marrow
increas
steroid
exposur
fat
degener
necrosi
consid
earli
sign
also
observ
li
et
al
also
shown
dexa
directli
induc
differenti
marrow
stromal
cell
larg
number
adipocyt
inhibit
osteogen
differenti
kitajima
et
al
show
matur
fat
cell
expos
highdos
gc
bigger
control
cell
deriv
bone
marrow
studi
jone
et
al
suggest
liquid
fat
thromboplastin
vasoact
substanc
releas
injur
marrow
adipocyt
affect
vascular
wall
endotheli
cell
produc
hypercoagul
state
endotheli
cell
therefor
studi
suggest
gc
might
caus
ischem
elev
intraoss
pressur
subsequ
decreas
blood
flow
femor
head
via
adipogenesi
fat
hypertrophi
bone
marrow
mention
gc
excess
caus
overproduct
reactiv
oxygen
speci
therebi
perturb
avail
vascular
endothelium
endotheli
cell
monolay
constitut
inner
line
vascular
wall
play
essenti
role
homeostasi
blood
due
uniqu
local
endothelium
continu
expos
inflammatori
cell
circul
factor
induc
endotheli
activ
andor
injuri
concept
focal
natur
system
haematolog
defect
result
local
hypercoagul
state
relev
femor
head
clot
abnorm
often
manifest
isol
endotheli
bed
defici
antithrombin
iii
protein
c
protein
result
deep
venou
thrombosi
extrem
thrombot
thrombocytopen
purpura
hemolyticurem
syndrom
result
microthrombot
lesion
detect
organ
except
liver
lung
antiphospholipidantibodi
syndrom
result
clot
particular
venou
arteri
area
includ
retina
placenta
heterogen
endotheli
cell
structur
amongst
mani
differ
organ
postul
probabl
caus
vari
clot
respons
separ
endotheli
bed
region
endotheli
bed
reb
differ
local
express
system
defect
region
endothelium
dysfunct
may
mechan
endothelium
dysfunct
activ
primarili
endothelium
secondari
stimul
could
activ
thrombosi
cascad
follow
ischemia
infarct
medic
gc
reinforc
vascular
process
lead
thrombot
occlus
directli
injur
endotheli
cell
amplifi
hypercoagul
gc
may
potenti
effect
endogen
hypercortisol
cush
diseas
preexist
condit
known
increas
risk
although
like
develop
follow
exogen
gc
administr
specif
bind
dexa
high
affin
low
capac
demonstr
isol
osteoblast
mostli
bind
nuclear
fraction
dissoci
constant
kd
approxim
nm
kd
triamcinolon
acetonid
anoth
exogen
gc
equal
nm
reflect
highaffin
bind
contrast
kd
gr
endogen
gc
cortisolcorticosteron
report
nm
thu
rel
bind
affin
steroid
receptor
found
greater
exogen
endogen
gc
use
high
dose
hydrocortison
methylprednisolon
extend
durat
shown
signific
risk
factor
patient
suffer
sever
acut
respiratori
syndrom
report
moder
high
dose
short
durat
steroid
usag
infertil
treatment
amongst
mani
diseas
process
also
report
treatment
hay
fever
corticosteroid
use
period
year
diseas
reportedli
associ
regardless
gc
treatment
amongst
patient
receiv
specif
gc
dose
unpredict
subset
develop
suggest
presenc
individu
differ
steroid
sensit
potenti
presenc
addit
specif
risk
factor
genet
risk
factor
intravascular
coagul
may
provid
answer
although
preval
coagul
abnorm
patient
gcinduc
increas
studi
compar
control
consider
proport
patient
demonstr
increas
preval
thrombophil
disord
furthermor
patient
gc
usag
thrombophil
factor
develop
likewis
although
alcohol
associ
etiolog
factor
heavi
alcohol
user
develop
diseas
therefor
difficult
say
whether
occur
patient
underli
predispos
factor
actual
due
underli
diseas
risk
factor
rather
gc
treatment
alcohol
mani
patient
predispos
factor
underli
diseas
system
lupu
erythematosu
acut
leukemia
also
administ
gc
part
treatment
regimen
similarli
therapeut
regimen
oncolog
includ
steroid
part
protocol
adjunct
measur
control
nausea
andor
prophylaxi
hypersensit
reaction
case
develop
chemotherapi
without
steroid
radiat
therapi
well
describ
oncolog
literatur
well
sever
investig
report
develop
patient
gc
replac
treatment
regimen
take
place
henc
current
pathophysiolog
model
put
forward
multipl
hit
theori
increas
number
risk
factor
risk
increas
amongst
mani
risk
factor
gc
lead
role
pathogenesi
multifactori
one
strategi
prevent
develop
reduc
potenti
risk
factor
exampl
one
strategi
use
anticoagul
lipidlow
agent
prevent
develop
shown
anim
model
experiment
studi
show
combin
use
anticoagul
lipidlow
agent
found
help
prevent
steroidinduc
rabbit
model
effort
need
better
comprehend
role
gc
trial
therapi
involv
antithrombot
drug
interfer
function
endotheli
cell
medic
intervent
promot
angiogenesi
administr
lipidlow
agent
antiapoptot
drug
may
use
treatment
patient
textbook
model
multipl
hit
theori
greater
number
risk
factor
risk
increas
nevertheless
gc
consid
lead
role
newer
data
gc
action
endotheli
cell
region
endotheli
bed
dysfunct
theori
hope
shed
new
light
gc
mechan
action
sever
pathway
gc
better
understood
futur
medic
surgic
manag
may
better
serv
treatment
modal
explor
new
import
pathway
